HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides.
Current candidate vaccines fail to protect primates against challenge with human immunodeficiency virus (HIV) in the presence of antibody responses; this underlines the importance of studying cell-mediated immunity to HIV and identifying specific epitopes that stimulate cytotoxic T lymphocytes (CTL)...
Príomhchruthaitheoirí: | Nixon, D, Townsend, A, Elvin, J, Rizza, C, Gallwey, J, Mcmichael, A |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
1988
|
Míreanna comhchosúla
Míreanna comhchosúla
-
HIV-gag-specific cytotoxic T lymphocytes.
de réir: Nixon, D, et al.
Foilsithe / Cruthaithe: (1989) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.
de réir: Townsend, A, et al.
Foilsithe / Cruthaithe: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides
de réir: Townsend, A, et al.
Foilsithe / Cruthaithe: (1986) -
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986.
de réir: Townsend, A, et al.
Foilsithe / Cruthaithe: (2006) -
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro.
de réir: Dorrell, L, et al.
Foilsithe / Cruthaithe: (2000)